We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drugmakers have asked the FDA to think “globally” with the international community as they weighed in on the agency’s draft guidance on established conditions for reporting chemical, manufacturing and control changes. Read More
Ohio Secretary of State John Husted is facing a lawsuit for failing to transmit the proposed Ohio Drug Price Relief Act citizen petition to the state’s General Assembly, as required by the state’s constitution. Read More
Botox maker Allergan shelled out $90 million upfront to acquire dermatology drugmaker Anterios in a deal that will provide access to a pipeline of neurotoxin therapies. Read More
Drugmakers need to better connect their clinical and R&D operations to cope with the growing cost and complexity of clinical trials amidst declining drug approvals. Read More
Dr. Reddy’s Laboratories has adopted a unique strategy to bypass legal issues surrounding its generic version of Nexium: changing the color of its capsules. Read More